US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
CH0229046H1
(de)
|
1985-03-30 |
1998-07-15 |
Stuart Alan Kauffman |
Method for obtaining dna, rna, peptides, polypeptinique. des or proteins by means of a dna recombinant tech
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
US5635600A
(en)
|
1986-07-07 |
1997-06-03 |
Trustees Of Dartmouth College |
Bifunctional and heteroantibodies specific for the high affinity Fc receptor for immunoglobulin G on human mononuclear phagocytes
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
US4704692A
(en)
|
1986-09-02 |
1987-11-03 |
Ladner Robert C |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
ES2063735T3
(es)
|
1986-10-22 |
1995-01-16 |
Abbott Lab |
Sales de acridinio quimioluminiscentes.
|
US5763192A
(en)
|
1986-11-20 |
1998-06-09 |
Ixsys, Incorporated |
Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
|
EP0832981A1
(en)
|
1987-02-17 |
1998-04-01 |
Pharming B.V. |
DNA sequences to target proteins to the mammary gland for efficient secretion
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
US4873316A
(en)
|
1987-06-23 |
1989-10-10 |
Biogen, Inc. |
Isolation of exogenous recombinant proteins from the milk of transgenic mammals
|
US5006309A
(en)
|
1988-04-22 |
1991-04-09 |
Abbott Laboratories |
Immunoassay device with liquid transfer between wells by washing
|
US5089424A
(en)
|
1988-06-14 |
1992-02-18 |
Abbott Laboratories |
Method and apparatus for heterogeneous chemiluminescence assay
|
JP3771253B2
(ja)
|
1988-09-02 |
2006-04-26 |
ダイアックス コープ. |
新規な結合タンパク質の生成と選択
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
US5241070A
(en)
|
1988-09-26 |
1993-08-31 |
Ciba Corning Diagnostics Corp. |
Nucleophilic polysubstituted aryl acridinium esters and uses thereof
|
US5063081A
(en)
|
1988-11-14 |
1991-11-05 |
I-Stat Corporation |
Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US5939272A
(en)
|
1989-01-10 |
1999-08-17 |
Biosite Diagnostics Incorporated |
Non-competitive threshold ligand-receptor assays
|
US5028535A
(en)
|
1989-01-10 |
1991-07-02 |
Biosite Diagnostics, Inc. |
Threshold ligand-receptor assay
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
US5780225A
(en)
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
WO1991010737A1
(en)
|
1990-01-11 |
1991-07-25 |
Molecular Affinities Corporation |
Production of antibodies using gene libraries
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
WO1991010741A1
(en)
|
1990-01-12 |
1991-07-25 |
Cell Genesys, Inc. |
Generation of xenogeneic antibodies
|
US5922615A
(en)
|
1990-03-12 |
1999-07-13 |
Biosite Diagnostics Incorporated |
Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
WO1992020791A1
(en)
|
1990-07-10 |
1992-11-26 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
EP0542810A1
(en)
|
1990-08-02 |
1993-05-26 |
B.R. Centre Limited |
Methods for the production of proteins with a desired function
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
AU658374B2
(en)
|
1990-09-14 |
1995-04-13 |
Biosite Diagnostics Incorporated |
Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
|
US5698426A
(en)
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
EP0564531B1
(en)
|
1990-12-03 |
1998-03-25 |
Genentech, Inc. |
Enrichment method for variant proteins with altered binding properties
|
ES2330052T3
(es)
|
1991-03-01 |
2009-12-03 |
Dyax Corporation |
Proteina quimerica que comprende micro-proteinas que tienen dos o mas puentes disulfuro y relaizaciones de las mismas.
|
WO1992018868A1
(en)
|
1991-04-10 |
1992-10-29 |
Biosite Diagnostics Incorporated |
Crosstalk inhibitors and their uses
|
EP0580737B1
(en)
|
1991-04-10 |
2004-06-16 |
The Scripps Research Institute |
Heterodimeric receptor libraries using phagemids
|
EP0579767B1
(en)
|
1991-04-11 |
2000-08-23 |
Biosite Diagnostics Inc. |
Novel conjugates and assays for simultaneous detection of multiple ligands
|
CA2069530A1
(en)
|
1991-06-03 |
1992-12-04 |
Cass J. Grandone |
Reagent pack for immunoassays
|
CA2110799A1
(en)
|
1991-06-14 |
1992-12-23 |
Arnold H. Horwitz |
Microbially-produced antibody fragments and their conjugates
|
DE4122599C2
(de)
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
ATE297465T1
(de)
|
1991-11-25 |
2005-06-15 |
Enzon Inc |
Verfahren zur herstellung von multivalenten antigenbindenden proteinen
|
ES2227512T3
(es)
|
1991-12-02 |
2005-04-01 |
Medical Research Council |
Produccion de anticuerpos contra auto-antigenos a partir de repertorios de segmentos de anticuerpos fijados en un fago.
|
ES2202310T3
(es)
|
1991-12-13 |
2004-04-01 |
Xoma Corporation |
Metodos y materiales para la preparacion de dominios variables de anticuerpos modificados y sus usos terapeuticos.
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
ES2148225T3
(es)
|
1992-03-30 |
2000-10-16 |
Abbott Lab |
Reactivos y procedimientos que permiten la deteccion y la cuantificacion de la tiroxina en muestras de fluido.
|
US5352803A
(en)
|
1992-03-30 |
1994-10-04 |
Abbott Laboratories |
5(6)-methyl substituted fluorescein derivatives
|
US5885527A
(en)
|
1992-05-21 |
1999-03-23 |
Biosite Diagnostics, Inc. |
Diagnostic devices and apparatus for the controlled movement of reagents without membrances
|
US6143576A
(en)
|
1992-05-21 |
2000-11-07 |
Biosite Diagnostics, Inc. |
Non-porous diagnostic devices for the controlled movement of reagents
|
CA2140638C
(en)
|
1992-07-24 |
2010-05-04 |
Raju Kucherlapati |
Generation of xenogeneic antibodies
|
US5824799A
(en)
|
1993-09-24 |
1998-10-20 |
Biosite Diagnostics Incorporated |
Hybrid phthalocyanine derivatives and their uses
|
WO1995015982A2
(en)
|
1993-12-08 |
1995-06-15 |
Genzyme Corporation |
Process for generating specific antibodies
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
PT1231268E
(pt)
|
1994-01-31 |
2005-11-30 |
Univ Boston |
Bancos de anticorpos policlonais
|
DE69527050T2
(de)
|
1994-03-07 |
2003-02-13 |
Medarex Inc |
Bispezifische moleküle mit klinischer verwendbarkeit
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
US6111166A
(en)
|
1994-09-19 |
2000-08-29 |
Medarex, Incorporated |
Transgenic mice expressing human Fcα and β receptors
|
US6091001A
(en)
|
1995-03-29 |
2000-07-18 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
US6130364A
(en)
|
1995-03-29 |
2000-10-10 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
WO1996033266A1
(en)
|
1995-04-21 |
1996-10-24 |
Cell Genesys, Inc. |
Generation of large genomic dna deletions
|
CA2219361C
(en)
|
1995-04-27 |
2012-02-28 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
EP0823941A4
(en)
|
1995-04-28 |
2001-09-19 |
Abgenix Inc |
HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
|
US6410690B1
(en)
|
1995-06-07 |
2002-06-25 |
Medarex, Inc. |
Therapeutic compounds comprised of anti-Fc receptor antibodies
|
JP2978435B2
(ja)
|
1996-01-24 |
1999-11-15 |
チッソ株式会社 |
アクリロキシプロピルシランの製造方法
|
SI9720020B
(en)
|
1996-02-09 |
2001-12-31 |
Basf Ag |
Human antibodies that bind human TNF alpha
|
US5714352A
(en)
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
US6699658B1
(en)
|
1996-05-31 |
2004-03-02 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
US5922845A
(en)
|
1996-07-11 |
1999-07-13 |
Medarex, Inc. |
Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
US6113855A
(en)
|
1996-11-15 |
2000-09-05 |
Biosite Diagnostics, Inc. |
Devices comprising multiple capillarity inducing surfaces
|
EP1500329B1
(en)
|
1996-12-03 |
2012-03-21 |
Amgen Fremont Inc. |
Human antibodies that specifically bind human TNF alpha
|
US6017517A
(en)
|
1996-12-18 |
2000-01-25 |
The Dial Corporation |
Method for treating human nails
|
ATE332368T1
(de)
|
1997-01-21 |
2006-07-15 |
Gen Hospital Corp |
Selektion von proteinen mittels rns-protein fusionen
|
US5947124A
(en)
|
1997-03-11 |
1999-09-07 |
Biosite Diagnostics Incorporated |
Diagnostic for determining the time of a heart attack
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
US6682928B2
(en)
|
1997-12-02 |
2004-01-27 |
Medarex, Inc. |
Cells expressing anti-Fc receptor binding components
|
EP1060193A2
(en)
|
1998-03-03 |
2000-12-20 |
Abgenix, Inc. |
Cd147 binding molecules as therapeutics
|
US20020029391A1
(en)
|
1998-04-15 |
2002-03-07 |
Claude Geoffrey Davis |
Epitope-driven human antibody production and gene expression profiling
|
CA2341029A1
(en)
|
1998-08-17 |
2000-02-24 |
Abgenix, Inc. |
Generation of modified molecules with increased serum half-lives
|
ES2301254T3
(es)
|
1998-11-18 |
2008-06-16 |
Genentech, Inc. |
Variantes de anticuerpos con una afinidad de union mayor en comparacion con los anticuerpos parentales.
|
ES2340745T3
(es)
|
1998-12-23 |
2010-06-08 |
Pfizer Inc. |
Anticuerpos monoclonales humanos contra ctla-4.
|
US6231768B1
(en)
|
1999-01-19 |
2001-05-15 |
Nalco Chemical Company |
Rheology modification of settled solids in mineral processing
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
IL145134A0
(en)
|
1999-03-25 |
2002-06-30 |
Knoll Gmbh |
Human antibodies that bind human il-12 and methods for producing
|
EP1212422B1
(en)
|
1999-08-24 |
2007-02-21 |
Medarex, Inc. |
Human ctla-4 antibodies and their uses
|
NZ520392A
(en)
|
2000-02-10 |
2005-04-29 |
Abbott Lab |
Antibodies that bind human interleukin-18 and methods of making and using
|
US6438498B1
(en)
|
2000-02-10 |
2002-08-20 |
I-Stat Corporation |
System, method and computer implemented process for assaying coagulation in fluid samples
|
KR20080074231A
(ko)
|
2000-06-29 |
2008-08-12 |
아보트 러보러터리즈 |
이중 특이성 항체 및 이의 제조 및 사용 방법
|
US20030199000A1
(en)
|
2001-08-20 |
2003-10-23 |
Valkirs Gunars E. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
ATE434040T1
(de)
|
2001-10-01 |
2009-07-15 |
Dyax Corp |
Mehrkettige eukaryontische display-vektoren und deren verwendungen
|
US7419821B2
(en)
|
2002-03-05 |
2008-09-02 |
I-Stat Corporation |
Apparatus and methods for analyte measurement and immunoassay
|
US20060134713A1
(en)
|
2002-03-21 |
2006-06-22 |
Lifescan, Inc. |
Biosensor apparatus and methods of use
|
US20040018577A1
(en)
|
2002-07-29 |
2004-01-29 |
Emerson Campbell John Lewis |
Multiple hybrid immunoassay
|
US7723099B2
(en)
|
2003-09-10 |
2010-05-25 |
Abbott Point Of Care Inc. |
Immunoassay device with immuno-reference electrode
|
US7682833B2
(en)
|
2003-09-10 |
2010-03-23 |
Abbott Point Of Care Inc. |
Immunoassay device with improved sample closure
|
EP2357477B1
(en)
|
2003-09-20 |
2017-11-08 |
Electrophoretics Limited |
Diagnostic method for brain damage-related disorders based on the detection of NDKA
|
EP2207033B1
(en)
|
2004-04-15 |
2014-06-18 |
University of Florida Research Foundation, Inc. |
Neural proteins as biomarkers for nervous system injury and other neural disorders
|
ES2367311T3
(es)
|
2004-04-15 |
2011-11-02 |
University Of Florida Research Foundation, Inc. |
Productos de degradación proteolítica de map-2 como biomarcadores de diagnóstico para las lesiones neurales.
|
US8492107B2
(en)
|
2004-04-15 |
2013-07-23 |
University Of Florida Research Foundation, Inc. |
Neural proteins as biomarkers for nervous system injury and other neural disorders
|
US20140303041A1
(en)
|
2004-04-15 |
2014-10-09 |
University Of Florida Research Foundation Inc. |
In vitro diagnostic devices for nervous system injury and other neural disorders
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
AU2006283532B2
(en)
|
2005-08-19 |
2012-04-26 |
Abbvie Inc. |
Dual variable domain immunoglobin and uses thereof
|
EP3115785A3
(en)
|
2008-02-04 |
2017-02-22 |
Banyan Biomarkers, Inc. |
Process to diagnose or treat brain injury
|
US20140342381A1
(en)
|
2008-08-11 |
2014-11-20 |
Banyan Biomarkers, Inc. |
Devices and methods for biomarker detection process and assay of neurological condition
|
EP4235181A3
(en)
|
2008-08-11 |
2024-02-28 |
Banyan Biomarkers Inc |
Biomarker detection process and assay of neurological condition
|
US20170315136A9
(en)
|
2009-06-19 |
2017-11-02 |
Banyan Biomarkers, Inc. |
Biomarker assay of neurological condition
|
EP3355059A3
(en)
|
2009-06-19 |
2018-09-26 |
Banyan Biomarkers, Inc. |
Biomarker assay of neurological condition
|
WO2011011334A2
(en)
|
2009-07-18 |
2011-01-27 |
Banyan Biomarkers, Inc. |
SYNERGISTIC BIOMARKER ASSAY OF NEUROLGICAL CONDITION USING S-100β
|
JP5909447B2
(ja)
|
2009-09-14 |
2016-04-26 |
バンヤン・バイオマーカーズ・インコーポレーテッド |
ニューロン損傷診断のためのマイクロrna、自己抗体およびタンパク質マーカー
|
WO2011160096A2
(en)
|
2010-06-17 |
2011-12-22 |
Banyan Biomarkers, Inc. |
Glial fibrillary acidic protein, autoantigens and autoantibodies thereto as biomarkers of neural injury or neurological disorder or condition
|
WO2012051519A2
(en)
|
2010-10-14 |
2012-04-19 |
The Johns Hopkins University |
Biomarkers of brain injury
|
US20120322682A1
(en)
|
2011-06-20 |
2012-12-20 |
William Marsh Rice University |
Brain injury biomarker panel
|
US9157910B2
(en)
|
2013-03-15 |
2015-10-13 |
Abbott Laboratories |
Assay with increased dynamic range
|
US20150141528A1
(en)
|
2013-05-31 |
2015-05-21 |
Banyan Biomarkers, Inc. |
Neural specific s100b for biomarker assays and devices for detection of a neurological condition
|
US9265441B2
(en)
|
2013-07-12 |
2016-02-23 |
Siemens Aktiengesellschaft |
Assessment of traumatic brain injury
|
US10534003B2
(en)
*
|
2013-07-17 |
2020-01-14 |
The Johns Hopkins University |
Multi-protein biomarker assay for brain injury detection and outcome
|
WO2015066211A1
(en)
|
2013-10-29 |
2015-05-07 |
Banyan Biomarkers, Inc. |
Uch-l1 isoforms, assays and devices for detection of a neurological condition
|
US20150224499A1
(en)
|
2014-02-13 |
2015-08-13 |
SFC Fluidics, Inc. |
Automated Microfluidic Sample Analyzer Platforms for Point of Care
|
WO2015157300A1
(en)
*
|
2014-04-07 |
2015-10-15 |
Iron Horse Diagnostics, Inc |
Traumatic brain injury and neurodegenerative biomarkers, methods, and systems
|
ES2792873T3
(es)
|
2014-09-22 |
2020-11-12 |
Japan Science & Tech Agency |
Método para detectar molécula diana y kit para su uso en dicho método
|
WO2016055148A2
(en)
|
2014-10-06 |
2016-04-14 |
Université De Genève |
Markers and their use in brain injury
|
CN107690582B
(zh)
|
2015-04-03 |
2023-10-20 |
雅培制药有限公司 |
用于样品分析的装置和方法
|
RU2712610C2
(ru)
|
2015-04-03 |
2020-01-29 |
Эбботт Лэборетриз |
Устройства и способы для анализа образца
|
FI20155280A
(fi)
|
2015-04-15 |
2016-10-16 |
Medicortex Finland Oy |
Aivovamman prognostisia ja diagnostisia glykaanipohjaisia biomarkkereita
|
EP3304090A4
(en)
|
2015-05-29 |
2018-11-07 |
Cedars-Sinai Medical Center |
Correlated peptides for quantitative mass spectrometry
|
BR112019006710A2
(pt)
|
2016-10-03 |
2019-06-25 |
Abbott Lab |
métodos aprimorados para avaliação do estado da uch-l1 em amostras de pacientes
|
EP3532496A1
(en)
|
2016-10-28 |
2019-09-04 |
Banyan Biomarkers, Inc. |
Antibodies to ubiquitin c-terminal hydrolase l1 (uch-l1) and glial fibrillary acidic protein (gfap) and related methods
|
WO2018136825A1
(en)
|
2017-01-19 |
2018-07-26 |
Cedars-Sinai Medical Center |
Highly multiplexed and mass spectrometry based methods to measuring 72 human proteins
|
US11016092B2
(en)
|
2017-03-23 |
2021-05-25 |
Abbott Laboratories |
Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase L1
|
WO2018191531A1
(en)
|
2017-04-15 |
2018-10-18 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
|
BR112019022476A2
(pt)
*
|
2017-04-28 |
2020-05-12 |
Abbott Laboratories |
Métodos para o auxílio no diagnóstico e determinação hiperagudos de lesão cerebral traumática usando biomarcadores iniciais em pelo menos duas amostras a partir do mesmo ser humano
|
CA3078725A1
(en)
|
2017-05-25 |
2018-11-29 |
Abbott Laboratories |
Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
|
BR112019025313A2
(pt)
|
2017-05-30 |
2020-06-23 |
Abbott Laboratories |
Métodos para auxílio no diagnóstico e avaliação de uma lesão cerebral traumática leve em um indivíduo humano usando troponina cardíaca i
|
CN107202890A
(zh)
*
|
2017-05-31 |
2017-09-26 |
湖州华远生物技术有限公司 |
用于轻中度脑损伤的快速诊断试剂及含有该试剂的试剂盒及该试剂盒的制备和检测方法
|
EP3721233A2
(en)
|
2017-12-09 |
2020-10-14 |
Abbott Laboratories |
Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (tbi), using glial fibrillary acidic protein (gfap) and/or ubiquitin carboxy-terminal hydrolase l1 (uch-l1)
|
US11016105B2
(en)
*
|
2017-12-09 |
2021-05-25 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1
|
EP3732489A1
(en)
|
2017-12-29 |
2020-11-04 |
Abbott Laboratories |
Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury
|
US20190302127A1
(en)
|
2018-03-30 |
2019-10-03 |
Sysmex Corporation |
Method for diagnosing traumatic brain injury
|